Cargando…

A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients

The adherence of type 2 diabetes mellitus (DM2) patients with an individual care plan (ICP) is often not satisfactory, nor does it allow for a significant improvement in outcome, because of poor accessibility to services, poor integration of pathway articulations, poor reconciliation with the patien...

Descripción completa

Detalles Bibliográficos
Autores principales: La Regina, Raffaele, Pandolfi, Dario, Stabile, Nicola, Beloni, Lucio, Glisenti, Fulvio, Griggio, Paola, La Regina, Micaela, La Regina, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712646/
https://www.ncbi.nlm.nih.gov/pubmed/33086680
http://dx.doi.org/10.3390/pharmacy8040193
_version_ 1783618416000630784
author La Regina, Raffaele
Pandolfi, Dario
Stabile, Nicola
Beloni, Lucio
Glisenti, Fulvio
Griggio, Paola
La Regina, Micaela
La Regina, Giuseppe
author_facet La Regina, Raffaele
Pandolfi, Dario
Stabile, Nicola
Beloni, Lucio
Glisenti, Fulvio
Griggio, Paola
La Regina, Micaela
La Regina, Giuseppe
author_sort La Regina, Raffaele
collection PubMed
description The adherence of type 2 diabetes mellitus (DM2) patients with an individual care plan (ICP) is often not satisfactory, nor does it allow for a significant improvement in outcome, because of poor accessibility to services, poor integration of pathway articulations, poor reconciliation with the patient’s life, or the lack of a constant reference person. The purpose of this study was to evaluate the contribution of community pharmacists and pharmacy services in improving adherence with periodic controls in DM2. The study was conducted at a rural pharmacy. A sample of 40 patients was calculated with respect to a historical cohort and subsequently enrolled. Clinical and personal data were collected in an electronic case report form. Pharmacists acting as a case manager followed patients carrying out their ICP developed by an attending physician. Some of the activities foreseen by the ICP, such as electrocardiogram, fundus examination, and self-analysis of blood and urine, were carried out directly in the pharmacy by the pharmacist through the use of telemedicine services and point of care units. Activities that could not be performed in the pharmacy were booked by the pharmacist at the accredited units. Examination results were electronically reported by the pharmacist to the attending physician. The primary endpoint was the variation in patient adherence with the ICP compared to a historical cohort. Secondary endpoints were variation in waiting time for the examinations, mean percentage change in glycated hemoglobin (HbA1c) and low-density lipoprotein (LDL) cholesterol levels and blood pressure, impact on healthcare-related costs, and perceived quality of care. Adherence to the ICP significantly increased. Waiting times were reduced and clinical outcomes improved with conceivable effects on costs. Patients appreciated the easier access to services. Community pharmacists and pharmacy services represent ideal actors and context that, integrated in the care network, can really favor ICP adherence and obtain daily morbidity reduction and cost savings through proper disease control and an early diagnosis of complications.
format Online
Article
Text
id pubmed-7712646
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77126462020-12-04 A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients La Regina, Raffaele Pandolfi, Dario Stabile, Nicola Beloni, Lucio Glisenti, Fulvio Griggio, Paola La Regina, Micaela La Regina, Giuseppe Pharmacy (Basel) Article The adherence of type 2 diabetes mellitus (DM2) patients with an individual care plan (ICP) is often not satisfactory, nor does it allow for a significant improvement in outcome, because of poor accessibility to services, poor integration of pathway articulations, poor reconciliation with the patient’s life, or the lack of a constant reference person. The purpose of this study was to evaluate the contribution of community pharmacists and pharmacy services in improving adherence with periodic controls in DM2. The study was conducted at a rural pharmacy. A sample of 40 patients was calculated with respect to a historical cohort and subsequently enrolled. Clinical and personal data were collected in an electronic case report form. Pharmacists acting as a case manager followed patients carrying out their ICP developed by an attending physician. Some of the activities foreseen by the ICP, such as electrocardiogram, fundus examination, and self-analysis of blood and urine, were carried out directly in the pharmacy by the pharmacist through the use of telemedicine services and point of care units. Activities that could not be performed in the pharmacy were booked by the pharmacist at the accredited units. Examination results were electronically reported by the pharmacist to the attending physician. The primary endpoint was the variation in patient adherence with the ICP compared to a historical cohort. Secondary endpoints were variation in waiting time for the examinations, mean percentage change in glycated hemoglobin (HbA1c) and low-density lipoprotein (LDL) cholesterol levels and blood pressure, impact on healthcare-related costs, and perceived quality of care. Adherence to the ICP significantly increased. Waiting times were reduced and clinical outcomes improved with conceivable effects on costs. Patients appreciated the easier access to services. Community pharmacists and pharmacy services represent ideal actors and context that, integrated in the care network, can really favor ICP adherence and obtain daily morbidity reduction and cost savings through proper disease control and an early diagnosis of complications. MDPI 2020-10-19 /pmc/articles/PMC7712646/ /pubmed/33086680 http://dx.doi.org/10.3390/pharmacy8040193 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
La Regina, Raffaele
Pandolfi, Dario
Stabile, Nicola
Beloni, Lucio
Glisenti, Fulvio
Griggio, Paola
La Regina, Micaela
La Regina, Giuseppe
A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients
title A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients
title_full A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients
title_fullStr A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients
title_full_unstemmed A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients
title_short A New Case Manager for Diabetic Patients: A Pilot Observational Study of the Role of Community Pharmacists and Pharmacy Services in the Case Management of Diabetic Patients
title_sort new case manager for diabetic patients: a pilot observational study of the role of community pharmacists and pharmacy services in the case management of diabetic patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712646/
https://www.ncbi.nlm.nih.gov/pubmed/33086680
http://dx.doi.org/10.3390/pharmacy8040193
work_keys_str_mv AT lareginaraffaele anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT pandolfidario anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT stabilenicola anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT belonilucio anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT glisentifulvio anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT griggiopaola anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT lareginamicaela anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT lareginagiuseppe anewcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT lareginaraffaele newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT pandolfidario newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT stabilenicola newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT belonilucio newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT glisentifulvio newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT griggiopaola newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT lareginamicaela newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients
AT lareginagiuseppe newcasemanagerfordiabeticpatientsapilotobservationalstudyoftheroleofcommunitypharmacistsandpharmacyservicesinthecasemanagementofdiabeticpatients